05-09-2023 12:36 PM | Source: LKP Securities Ltd
View on Mankind Pharma IPO from S Ranganathan, LKP Securities
Below is View on Mankind Pharma IPO by S Ranganathan, Head of Research at LKP Securities
Fast Growing India Centric Mankind Pharma truly deserves credit for bringing back life into the Primary Market during CY 2023 with a stellar listing which provided a 30% return to Retail Investors and the icing on the cake was the allotment itself wherein almost all retail investors were allotted the shares.
Above views are of the author and not of the website kindly read disclaimer
Latest News
Nifty, Bank Nifty and Stocks to watch out 27.04.2024...
FPI selling in equity markets getting absorbed by do...
India set to sign trade deal with Oman to expand its...
India Yes Bank posts Q4 profit beat on lower provisions
Reduce Dr Reddys? Ltd For Target Rs.1,808 - Yes Secu...
Buy Restaurant Brands Asia Ltd For Target Rs.140 -...
Buy Craftsman Automation Ltd For Target Rs.5,395 - ...
Add Larsen & Toubro Ltd For Target Rs.3,444 - Yes Se...
Neutral M&M Financial Services Ltd For Target Rs.300...
Add Aditya Birla Sun Life AMC Ltd For Target Rs.525 ...
Tag News
We anticipate immense potential benefits from the upcoming Sovereign Gold Bond Tranche in FY...
Weekly Market Analysis : Markets strengthened recovery and gained nearly 2% in the passing week Says Mr. Ajit Mishra, Religare Broking
Weekly market outlook : The market is eagerly awaiting data on inflation and industrial production to provide further guidance Says Vinod Nair, Geojit Financial Services
Monthly Debt Market Update, September 2023: CareEdge Ratings